Valion Bio, Inc.
VBIO
$1.10
-$0.01-0.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.88M | -7.51M | -6.34M | -5.68M | -5.66M |
| Total Depreciation and Amortization | 5.00K | 275.00K | 276.00K | 307.00K | 352.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.33M | 1.44M | 935.00K | 821.00K | 771.00K |
| Change in Net Operating Assets | 452.00K | -285.00K | -358.00K | -400.00K | -1.19M |
| Cash from Operations | -7.00M | -6.08M | -5.49M | -4.95M | -5.73M |
| Capital Expenditure | -38.00K | -13.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -667.00K | -543.00K | -543.00K | -526.00K | -- |
| Cash from Investing | -705.00K | -556.00K | -546.00K | -526.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.45M | 3.56M | 3.15M | 4.49M | 4.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 16.21M | 4.34M | 585.00K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -308.00K | -5.00K | -207.00K | -15.00K | -49.00K |
| Cash from Financing | 18.35M | 7.89M | 3.53M | 4.48M | 4.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.64M | 1.26M | -2.51M | -999.00K | -1.39M |